Search for Clinical Trial Results
Poxviridae Infections - 25 Studies Found
Status | Study |
Completed |
Study Name: Safety and Immunogenicity Study of AIDS Vaccine (Combined Use of DNA Vaccine and Recombinant Vaccinia Virus Tiantan) Condition: AIDS Date: 2012-09-12 Interventions:
|
Completed |
Study Name: A Phase II Trial to Compare a Liquid-frozen and a Freeze-dried Formulation of IMVAMUNE (MVA-BN®) Smallpox Vaccine in Vaccinia-naïve Healthy Subjects Condition: Smallpox Date: 2012-08-14 Interventions:
|
Completed |
Study Name: A Phase 2a Study of Modified Vaccinia Virus to Treat Sorafenib-naïve Advanced Liver Cancer Condition: Hepatocellular Carinoma Date: 2012-06-23 Interventions: Biological: JX-594 recombinant vaccina GM-CSF Enrolled patients will receive 5 weekly IV infusions on Da |
Completed |
Study Name: Post-licensure Department of Defense (DOD) Screening Accuracy Study in Military Personnel Condition: Smallpox Date: 2012-02-23 |
Completed |
Study Name: Safety of and Immune Response to a DNA HIV Vaccine Boosted With a Modified Vaccinia HIV Vaccine and Protein HIV Vaccine in Healthy Adults Condition:
Date: 2011-06-17 Interventions:
|
Enrolling by invitation |
Study Name: VA-005 Clinical Outcomes of VIGIV Treatment of Smallpox Vaccination Complications or Vaccinia Infection Condition: Complication of Smallpox Vaccination Date: 2011-06-14 Interventions: Biological: VIGIV VIGIV is licensed in US, by the FDA, for the treatment of complications of smallpox va |
Completed |
Study Name: Safety and Efficacy of CJ Smallpox Vaccine in Previously Vaccinated Healthy Volunteers Condition: Smallpox Date: 2011-03-15 Interventions: Drug: smallpox vaccine CJ-50300 Conventional CJ-50300 2.5 x 100000 pfu/dose vaccination |
Completed |
Study Name: Vaccinia Vaccine (ACAM2000) for the Production of Vaccinia Immune Globulin Intravenous(VIGIV) Condition: Smallpox Vaccination Date: 2010-07-05 Interventions: Biological: ACAM2000 Percutaneous administration of a droplet (2.5µg) of ACAM2000 using a bifurcate |
Completed |
Study Name: A Trial to Evaluate Immunogenicity and Safety of Three Consecutive Production Lots of IMVAMUNE® (MVA-BN®) Smallpox Vaccine in Healthy, Vaccinia-naïve Subjects Condition: Smallpox Date: 2010-06-14 Interventions:
|
Completed |
Study Name: Safety and Efficacy of CJ Smallpox Vaccine in Healthy Volunteers Condition: Smallpox Date: 2010-01-24 Interventions: Drug: smallpox vaccine CJ-50300 Conventional CJ-50300 2.5 x 100000 pfu/dose vaccination |